Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study

NCT00775164 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Inadequate enrollment

Conditions

Obesity
Insulin Resistance

Interventions

DRUG: pioglitazone
DRUG: Metformin

Sponsor

University of Minnesota